Evaluation of Immunologic Parameters in Canine Glioma Patients Treated with an Oncolytic Herpes Virus

被引：0
|
作者：
Estevez-Ordonez, Dagoberto
Chambers, Melissa
Foote, Jeremy
Bentley, R. Timothy
Botta, Davide
Crossman, David
Della Manna, Deborah
Koehler, Jey
Langford, Catherine
Miller, Margaret
Markert, James [1 ]
Oliver, Alicia
Omar, Nidal [1 ]
Platt, Simon
Rissi, Daniel
Shores, Andy
Sorjonen, Donald
Yang, Eddy
Yanke, Amy
Gillespie, Yancey [1 ]
机构：
[1] Univ Alabama Birmingham, Neurosurg, Birmingham, AL USA
来源：
JOURNAL OF NEUROSURGERY | 2022年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
454
引用
收藏
页数：1
相关论文
共 50 条
  • [1] An oncolytic herpes virus for nestin-producing glioma cells
    不详
    CANCER BIOLOGY & THERAPY, 2005, 4 (05) : VI - VII
  • [2] DEMONSTRATION BY PLAQUE REDUCTION TECHNIQUE OF IMMUNOLOGIC RELATIONSHIP BETWEEN CANINE HERPES VIRUS AND HERPES SIMPLEX VIRUS
    AURELIAN, L
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1968, 127 (02): : 485 - &
  • [3] Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
    Hu, Mingming
    Liao, Xuliang
    Tao, Yi
    Chen, Yaohui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] Synergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review
    Iqbal, Javed
    Hafeez, Muhammad Hassan
    Amin, Aamir
    Moradi, Iman
    Chhabra, Anisha
    Iqbal, Ather
    Patel, Tirath
    Shafique, Muhammad Ashir
    Nadeem, Abdullah
    Jamil, Usama
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (09): : 5354 - 5360
  • [5] Tumour-specific triple-regulated oncolytic herpes virus to target glioma
    Delwar, Zahid M.
    Liu, Guoyu
    Kuo, Yvonne
    Lee, Cleo
    Bu, Luke
    Rennie, Paul S.
    Jia, William W.
    ONCOTARGET, 2016, 7 (19) : 28658 - 28669
  • [6] Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
    Gillory, Lauren A.
    Megison, Michael L.
    Stewart, Jerry E.
    Mroczek-Musulman, Elizabeth
    Nabers, Hugh C.
    Waters, Alicia M.
    Kelly, Virginia
    Coleman, Jennifer M.
    Markert, James M.
    Gillespie, G. Yancey
    Friedman, Gregory K.
    Beierle, Elizabeth A.
    PLOS ONE, 2013, 8 (10):
  • [7] Preclinical Safety Evaluation of Oncolytic Herpes Simplex Virus Type 2
    Wang, Yang
    Zhou, Xiaobing
    Wu, Zhen
    Hu, Han
    Jin, Jing
    Hu, Yanping
    Dong, Yuting
    Zou, Jianwen
    Mao, Zeyong
    Shi, Xiaotai
    Huo, Yan
    Lyu, Jianjun
    Fang, Zhizheng
    Zhang, Wen
    Zhu, Yujie
    Li, Bo
    Liu, Binlei
    HUMAN GENE THERAPY, 2019, 30 (05) : 651 - 660
  • [8] Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application
    Hua, Lingyang
    Wakimoto, Hiroaki
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 845 - 854
  • [9] Oncolytic herpes simplex virus expressing interleukin-12 for treating glioma stem cells
    Cheema, Tooba A.
    Wakimoto, Hiroaki
    Rabkin, Samuel
    Martuza, Robert L.
    CANCER RESEARCH, 2011, 71
  • [10] Preclinical evaluation of an engineered oncolytic herpes simplex virus for pediatric osteosarcoma.
    Hutchins, Sara
    Marayati, Raoud
    Bownes, Laura V.
    Quinn, Colin H.
    Stewart, Jerry E.
    Friedman, Gregory K.
    Coleman, Jennifer M.
    Gillespie, G. Yancey
    Markert, James M.
    Beierle, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345